GE HealthCare Mammography
- 10 years of contrast mammography leadership worldwide for diagnostic breast imaging.
- 83% of the patient rated their experience with Senographe Pristina better than with previous system*
- Amongst patients who used the patient-assisted compression device Pristina Dueta, 80% found it improved the comfort of their exam, and 54% found it led to less anxiety**
- First to Commercialize Mammography in the world in 1966.
- Largest global installed base for breast imaging.1
- More than 100 clinical publications worldwide.1
- Pristina mammography has the lowest patient dose of all FDA approved DBT system***
- Two out of three patients prefer GE's contrast-enhanced mammography experience to a breast MRI, with faster procedure time, greater comfort, lower noise level and lower rates of anxiety****
Visit the Women’s Health Department at our Virtual Care Center
Because we want to remain close to you at any time, we are bringing the Virtual Care Center experience at your doorstep.
- Explore the solutions for your care department
- Learn about our latest innovations
- Contact us or ask for a demo
1. Superior diagnostic accuracy demonstrated in a reader study comparing the ROC AUC of GE screening protocol (V-Preview + 3D CC/MLO with 3D in STD mode) to that of 2D FFDM alone. V-Preview is the 2D synthesized image generated by GE Seno Iris mammography software from GE DBT images. FDA PMA P130020
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P130020.
Comparison of patient dose delivered by FDA approved DBT devices as of February 2018 for a breast of average density, based on data presented in [1-2] and data on file. Device comparison includes GE SenoClaire, GE Senographe Pristina 3D in STD mode, Hologic Selenia Dimensions, Siemens Mammomat Inspiration, Fuji Aspire Cristalle [1. Bouwman, R. W. and al., et. 2015, Physics in Medicine & Biology, pp. 7893-7907; 2. NHSBSP Equipment Reports 1306, 1404, 1307, and on Fujifilm AMULET Innovality.]